Patents by Inventor Andre Hazout

Andre Hazout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF DEOXYRIBONUCLEASE I IN THE TREATMENT OF ENDOMETRIOSIS IN PATIENTS WITH AN EPIGENETIC SIGNATURE OF ENDOMETRIOSIS ON CELL-FREE DNA
    Publication number: 20240050536
    Abstract: The invention relates to a method for treating endometriosis, by administering DNase I, and, in particular, for treating a patient with a cell-free DNA level above normal, a fortiori if this cell-free DNA has a methylation profile typical of endometriosis.
    Type: Application
    Filed: January 5, 2022
    Publication date: February 15, 2024
    Inventors: André HAZOUT, Moncef BEN KHALIFA
  • EPIGENETIC SIGNATURE OF ENDOMETRIOSIS ON THE BASIS OF ACELLULAR DNA
    Publication number: 20220282331
    Abstract: Disclosed is a method for non-invasive diagnosis of endometriosis on the basis of the measurement of the level of acellular DNA in a biological sample from an individual, wherein a measured level of acellular DNA lower than the reference threshold can be used to rule out an endometriosis diagnosis. When the measured level of acellular DNA is greater than the reference threshold, a step of measuring the methylation level of at least 15 genes involved in endometriosis enables the diagnosis of endometriosis to be made in the patient tested.
    Type: Application
    Filed: July 6, 2020
    Publication date: September 8, 2022
    Inventors: André HAZOUT, Moncef BEN KHALIFA
  • Cell-free DNA as a therapeutic target for female infertility and diagnostic marker
    Patent number: 9950040
    Abstract: The present invention pertains to the use of DNase to treat female infertility and the use of cfDNA as a marker of female infertility.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: April 24, 2018
    Assignee: FERRING B.V.
    Inventor: Andre Hazout
  • CELL-FREE DNA AS A THERAPEUTIC TARGET FOR FEMALE INFERTILITY AND DIAGNOSTIC MARKER
    Publication number: 20150246103
    Abstract: The present invention pertains to the use of DNase to treat female infertility and the use of cfDNA as a marker of female infertility.
    Type: Application
    Filed: August 1, 2013
    Publication date: September 3, 2015
    Inventor: Andre Hazout